scholarly article | Q13442814 |
P356 | DOI | 10.1002/JCPH.843 |
P698 | PubMed publication ID | 27922719 |
P50 | author | Jessica E Haberer | Q57891949 |
Craig W Hendrix | Q59688777 | ||
David R Bangsberg | Q60227555 | ||
Jared M Baeten | Q89443633 | ||
Michael J Fossler | Q97535318 | ||
Ayyappa Chaturvedula | Q117266738 | ||
Connie Celum | Q42571941 | ||
P2093 | author name string | Mark Sale | |
Kumpal Madrasi | |||
P2860 | cites work | The impact of patient compliance on drug concentration profile in multiple doses. | Q52888493 |
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men | Q24612082 | ||
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women | Q28270788 | ||
Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infection | Q28481276 | ||
Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa | Q28533158 | ||
Preexposure prophylaxis for HIV infection among African women | Q29620077 | ||
Sexual Relationships Outside Primary Partnerships and Abstinence Are Associated With Lower Adherence and Adherence Gaps: Data From the Partners PrEP Ancillary Adherence Study | Q30944686 | ||
A new taxonomy for describing and defining adherence to medications | Q31054192 | ||
Modelling overdispersion and Markovian features in count data | Q33508253 | ||
An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in Uganda | Q34314648 | ||
Patient adherence to treatment: three decades of research. A comprehensive review | Q34419183 | ||
How often is medication taken as prescribed? A novel assessment technique | Q34525872 | ||
Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation | Q34606560 | ||
Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm | Q35780443 | ||
Clinical trial simulation: a tool for understanding study failures and preventing them | Q36055589 | ||
Emtricitabine: a novel nucleoside reverse transcriptase inhibitor | Q36202241 | ||
Diagnosing model diagnostics | Q36850144 | ||
Estimation of tenofovir's population pharmacokinetic parameters without reliable dosing histories and application to tracing dosing history using simulation strategies | Q37210864 | ||
Single dose pharmacokinetics of oral tenofovir in plasma, peripheral blood mononuclear cells, colonic tissue, and vaginal tissue | Q37258298 | ||
Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories | Q37937669 | ||
Transition modeling of neuropsychiatric impairment in HIV. | Q38854880 | ||
Comparison of subjective and objective adherence measures for preexposure prophylaxis against HIV infection among serodiscordant couples in East Africa | Q38856099 | ||
Markov model for characterizing neuropsychologic impairment and Monte Carlo simulation for optimizing efavirenz therapy. | Q38859179 | ||
A Markov mixed effect regression model for drug compliance | Q40834986 | ||
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. | Q41730905 | ||
Modelling a spontaneously reported side effect by use of a Markov mixed-effects model | Q42673308 | ||
A dynamic model of hand-and-foot syndrome in patients receiving capecitabine | Q44014861 | ||
Methods for measuring, enhancing, and accounting for medication adherence in clinical trials. | Q46630774 | ||
Exposure-response analysis for spontaneously reported dizziness in pregabalin-treated patient with generalized anxiety disorder | Q46769733 | ||
A pharmacodynamic Markov mixed-effects model for the effect of temazepam on sleep | Q48714607 | ||
Time to stop counting the tablets? | Q52876428 | ||
P433 | issue | 5 | |
P921 | main subject | covariate | Q5178903 |
P304 | page(s) | 606-615 | |
P577 | publication date | 2016-12-06 | |
P1433 | published in | The Journal of Clinical Pharmacology | Q7743562 |
P1476 | title | Markov Mixed Effects Modeling Using Electronic Adherence Monitoring Records Identifies Influential Covariates to HIV Preexposure Prophylaxis | |
P478 | volume | 57 |
Q92238024 | Assessment of Demographic and Socio-Behavioral Factors on Adherence to HIV Pre-Exposure Prophylaxis Using a Markov Modeling Approach | cites work | P2860 |